-
Mashup Score: 0Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial - 1 year(s) ago
Dapagliflozin reduced the risk of first and total non-elective hospitalisations for any cause in people with type 2 diabetes, regardless of the presence of atherosclerotic cardiovascular disease, including hospitalisations not directly attributed to cardiac, kidney, or metabolic causes. These findings might have implications on health-related quality of life for people with type 2 diabetes and on…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 5Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial - 1 year(s) ago
Dapagliflozin reduced the risk of first and total non-elective hospitalisations for any cause in people with type 2 diabetes, regardless of the presence of atherosclerotic cardiovascular disease, including hospitalisations not directly attributed to cardiac, kidney, or metabolic causes. These findings might have implications on health-related quality of life for people with type 2 diabetes and on…
Categories: Endocrinology, Latest HeadlinesTweet-
Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial https://t.co/4OOalOalfR #T2D
-
-
Mashup Score: 0Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial - 1 year(s) ago
Dapagliflozin reduced the risk of first and total non-elective hospitalisations for any cause in people with type 2 diabetes, regardless of the presence of atherosclerotic cardiovascular disease, including hospitalisations not directly attributed to cardiac, kidney, or metabolic causes. These findings might have implications on health-related quality of life for people with type 2 diabetes and on…
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial https://t.co/4OOalOaT5p #T2D
-
-
Mashup Score: 2Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial - 1 year(s) ago
Dapagliflozin reduced the risk of first and total non-elective hospitalisations for any cause in people with type 2 diabetes, regardless of the presence of atherosclerotic cardiovascular disease, including hospitalisations not directly attributed to cardiac, kidney, or metabolic causes. These findings might have implications on health-related quality of life for people with type 2 diabetes and on…
Categories: Endocrinology, Latest HeadlinesTweet-
New—Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial https://t.co/4OOalOalfR #T2D
-
-
Mashup Score: 0The changing character of diabetes complications - 2 year(s) ago
Several factors influence the course of a chronic disease such as diabetes, including our understanding of the disease epidemiology, public health initiatives, and the introduction of new therapies and interventions. The cumulative effect of these factors is best studied by observations made over long periods of time. Although randomised controlled trials and long-term follow up of well-defined…
Categories: Endocrinology, Latest HeadlinesTweet-
Srikanth Bellary comments on: The changing character of diabetes complications https://t.co/icTH70U5CM #diabetes #T1D #T2D #hospitalisations https://t.co/HfCXUCm0HZ
-
-
Mashup Score: 2
Diabetes leads to a wide range of established vascular and metabolic complications that has resulted in the implementation of diverse prevention programmes across high-income countries. Diabetes has also been associated with an increased risk of a broader set of conditions including cancers, liver disease, and common infections. We aimed to examine the trends in a broad set of cause-specific…
Categories: Endocrinology, Latest HeadlinesTweet-
Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records https://t.co/HN4MsP9L6p #diabetes #T1D #T2D #hospitalisations #openaccess
-
-
Mashup Score: 1The changing character of diabetes complications - 2 year(s) ago
Several factors influence the course of a chronic disease such as diabetes, including our understanding of the disease epidemiology, public health initiatives, and the introduction of new therapies and interventions. The cumulative effect of these factors is best studied by observations made over long periods of time. Although randomised controlled trials and long-term follow up of well-defined…
Categories: Endocrinology, Latest HeadlinesTweet-
Srikanth Bellary comments on: The changing character of #diabetes complications https://t.co/icTH70U5CM #T1D #T2D #hospitalisations #FREE to read with registration (also FREE) https://t.co/lEOdnSk2p9
-
-
Mashup Score: 10The Lancet Diabetes & Endocrinology, January 2022, Volume 10, Issue 1, Pages 1-84, e1 - 2 year(s) ago
Explore the current issue of The Lancet Diabetes & Endocrinology, a monthly journal focussed on diabetes, endocrinology, and metabolism
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
The January Issue of @TheLancetEndo is now online, featuring new-onset #diabetes, #HeartFailure, diabetes #hospitalisations, #glycaemic management, #DIYAPS, #OpenSource, #telehealth, #COVID19, #adrenal, #T1D, #T2D, childhood #obesity, #insulin & more https://t.co/4pkJzTAudc https://t.co/XFAN4HHTh9
-
-
Mashup Score: 0
Skip Nav Destination Search Results for Self-care, symptom experience, needs, and past health-care utilization in individuals with heart…
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In patients with #HeartFailure: #hospitalisations are positively correlated with self-care; symptom experience with needs—a cross-sectional study: https://t.co/nNSxk56Ejk @prof_stromberg @escardio @EditorEJCN @LeonieKlompstra #ACNAP #cardiotwitter https://t.co/ORCpHNKSgo
-
Online—Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial https://t.co/4OOalOaT5p #T2D #SGLT2 inhibitors